Please assess the completion status of the following clinical trial:

Trial Title: 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled to undergo standard of care biopsy for suspected prostate cancer, or re-biopsy with prior negative systemic biopsy or restaging biopsy in patients with known prostate cancer on active surveillance~Exclusion Criteria:~* History of myocardial infarction within 6 months of the enrollment~* Active infection (except mild upper respiratory infections)~* Active prostatitis~* Non-prostate cancers currently on treatment

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Diagnostic (18F-FMAU PET/CT) (Type: EXPERIMENTAL): Patients receive radiotracer F 18 d-FMAU IV over 1 minute and then undergo 18F-FMAU PET/CT on day 1. Patients then undergo standard of care multiparametic MRI and standard of care transrectal ultrasound-guided biopsy.

Based on this trial design, predict the completion outcome and termination type (if applicable).